回应 Toshihide Tsuda、Yumiko Miyano 和 Eiji Yamamoto [1]。
Response to Toshihide Tsuda, Yumiko Miyano and Eiji Yamamoto [1].
机构信息
International Agency for Research on Cancer, World Health Organisation (IARC/WHO), Lyon, France.
Department of Surgery-Otolaryngology-Head and Neck Surgery, The Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine, Hanover, NH, USA.
出版信息
Environ Health. 2023 Jan 26;22(1):13. doi: 10.1186/s12940-022-00952-x.
BACKGROUND
Using a toolkit approach, Tsuda et al. critiqued work carried out by or in collaboration with the International Agency for Research on Cancer (IARC/WHO), including the IARC technical publication No. 46 on "Thyroid health monitoring after nuclear accidents" (TM-NUC), the project on nuclear emergency situations and improvement on medical and health surveillance (SHAMISEN), and the IARC-led work on global thyroid cancer incidence patterns as per IARC core mandate.
MAIN BODY
We respond on the criticism of the recommendations of the IARC technical publication No. 46, and of global thyroid cancer incidence evaluation.
CONCLUSION
After nuclear accidents, overdiagnosis can still happen and must be included in informed decision making when providing a system of optimal help for cases of radiation-induced thyroid cancer, to minimize harm to people by helping them avoid diagnostics and treatment they may not need.
背景
津田等人采用工具包方法，对国际癌症研究机构（IARC/WHO）开展或合作开展的工作进行了批判，包括 IARC 技术出版物第 46 号《核事故后甲状腺健康监测》（TM-NUC）、核紧急情况和改进医疗和卫生监测项目（SHAMISEN），以及 IARC 主导的全球甲状腺癌发病模式工作，这符合 IARC 的核心任务。
正文
我们对 IARC 技术出版物第 46 号的建议以及全球甲状腺癌发病率评估的批评作出回应。
结论
核事故后，仍可能出现过度诊断，在为辐射引起的甲状腺癌提供最佳帮助系统时，必须将其纳入知情决策，以帮助人们避免可能不需要的诊断和治疗，从而最大程度地减少对他们的伤害。
Zotero 插件